Uploaded model
- Developed by: student-abdullah
- License: apache-2.0
- Finetuned from model: meta-llama/Llama-3.2-1B
- Created on: 1st October, 2024
Acknowledgement
<img src="https://raw.githubusercontent.com/unslothai/unsloth/main/images/unsloth%20made%20with%20love.png" width="200"/>
Model Description
This model is fine-tuned from the meta-llama/Llama-3.2-1B base model to enhance its capabilities in generating relevant and accurate responses related to generic medications under the PMBJP scheme. The fine-tuning process included the following hyperparameters:
- Fine Tuning Template: Llama Q&A
- Max Tokens: 512
- LoRA Alpha: 10
- LoRA Rank (r): 128
- Learning rate: 1e-5
- Gradient Accumulation Steps: 2
- Batch Size: 4
- Quantization: None
Model Quantitative Performace
- Training Quantitative Loss: 0.2073 (at final 5200th Step)
Limitations
- Token Limitations: With a max token limit of 512, the model might not handle very long queries or contexts effectively.
- Training Data Limitations: The model’s performance is contingent on the quality and coverage of the fine-tuning dataset, which may affect its generalizability to different contexts or medications not covered in the dataset.
- Potential Biases: As with any model fine-tuned on specific data, there may be biases based on the dataset used for training.
Model Performace Evaluation:
- Evaluation on 1000 Questions based on dataset (to evaluate the finetuned knowledge base)
- Correct Responses: 79.03%
- Incorrect Responses: 20.97%
<p align="center">
<img src="https://cdn-uploads.huggingface.co/production/uploads/669100cee760dfd88da676a6/AWkIpdkz-jyXlg3kP8g-r.png" width="20%" style="display:inline-block;"/>
<img src="https://cdn-uploads.huggingface.co/production/uploads/669100cee760dfd88da676a6/6Q-DW_jRFwHzWt1wtbFR3.png" width="35%" style="display:inline-block;"/>
<img src="https://cdn-uploads.huggingface.co/production/uploads/669100cee760dfd88da676a6/nG0b-w6wmj6bJgelzXjHY.png" width="35%" style="display:inline-block;"/>
</p>